ZTS
Zoetis Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -7.1% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 944.24K | $65.94M | n/a | n/a |
| Q2 2026 | 173 | +5 | 278.21M | $20.02B | +9 | −5 |
| Q1 2026 | 172 | -5 | 287.89M | $34.03B | +1 | −7 |
| Q4 2025 | 176 | -2 | 318.69M | $40.10B | +3 | −4 |
| Q3 2025 | 25 | -1 | 154.48M | $22.59B | n/a | −2 |
| Q2 2025 | 24 | +2 | 132.57M | $20.67B | +2 | n/a |
| Q1 2025 | 19 | 0 | 50.59M | $8.32B | n/a | n/a |
| Q4 2024 | 19 | +1 | 54.43M | $8.86B | +1 | n/a |
| Q3 2024 | 17 | 0 | 31.69M | $6.18B | +1 | −1 |
| Q2 2024 | 17 | n/a | 38.28M | $6.63B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 19.80M | -0.2% | $3.26B | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 10.99M | +3.5% | $1.80B | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 6.07M | -12.8% | $998.66M | 0.2% | ▼ Trim | 4 | SEC ↗ ×4 |
| 4 | Norges Bank ✦ (passief) | 5.09M | +0.7% | $838.59M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 5 | Capital World Investors ✦ | 3.97M | -39.5% | $653.68M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.46M | -20.2% | $241.18M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 7 | Arrowstreet Capital ✦ | 648.41K | +142.2% | $106.76M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 616.38K | +109.9% | $100.57M | 0.1% | ▲ Add | 4 | SEC ↗ ×6 |
| 9 | Millennium Management ✦ | 544.43K | +28.0% | $89.64M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 10 | Marshall Wace ✦ | 363.59K | -53.9% | $59.87M | 0.1% | ▼ Trim | 4 | SEC ↗ ×3 |
| 11 | Adage Capital Partners ✦ | 344.34K | +154.6% | $56.70M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 331.27K | +14.8% | $54.54M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 144.03K | +46.4% | $23.72M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 102.92K | -25.6% | $16.95M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 83.19K | -92.4% | $13.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 17.93K | +124.9% | $2.95M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | GAMCO Investors ✦ | 11.79K | -11.9% | $1.94M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 2.86K | +0.4% | $471,228 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Dodge & Cox ✦ | 1.70K | 0.0% | $279,905 | 0.0% | Held | 4 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,596 houders, 404.54M aandelen, $46.32B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.